We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+3.82%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$5.38M
Cap. Flow
-$5.42M
Cap. Flow %
-4.55%
Top 10 Hldgs %
36.72%
Holding
80
New
8
Increased
27
Reduced
7
Closed
11
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$1.8M
2
WBA icon
Walgreens Boots Alliance
WBA
+$1.67M
3
BIDU icon
Baidu
BIDU
+$1.6M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.53M
5
BABA icon
Alibaba
BABA
+$1.47M

Top Sells

Rank Stock Value
1
IMGN icon
Immunogen Inc
IMGN
+$14.8M
2
NHC icon
National Healthcare
NHC
+$2.77M
3
TAST icon
Carrols Restaurant Group, Inc.
TAST
+$2.76M
4
FCX icon
Freeport-McMoran
FCX
+$2.13M
5
BGC icon
BGC Group
BGC
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 42.71%
2 Industrials 9.53%
3 Technology 8.54%
4 Materials 8.18%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TALO icon
26
Talos Energy
TALO
$2.84B
$1.74M 1.46%
125,000
+55,000
+79% +$718K
2020 Q4
13 quarters
INCY icon
27
Incyte
INCY
$23B
$1.71M 1.44%
+30,000
New +$1.8M
2024 Q1
0 quarters
BIDU icon
28
Baidu
BIDU
$28.1B
$1.58M 1.33%
+15,000
New +$1.6M
2024 Q1
0 quarters
FHN icon
29
First Horizon
FHN
$10.8B
$1.54M 1.29%
100,000
+50,000
+100% +$718K
2023 Q4
1 quarter
RBCAA icon
30
Republic Bancorp
RBCAA
$1.8B
$1.53M 1.29%
30,000
+2,500
+9% +$126K
2020 Q4
13 quarters
PAAS icon
31
Pan American Silver
PAAS
$18.1B
$1.51M 1.27%
100,000
– –
2023 Q2
3 quarters
JAZZ icon
32
Jazz Pharmaceuticals
JAZZ
$13.9B
$1.51M 1.26%
+12,500
New +$1.53M
2024 Q1
0 quarters
CGAU icon
33
Centerra Gold
CGAU
$4.3B
$1.48M 1.24%
250,000
+100,000
+67% +$542K
2023 Q4
1 quarter
DIT icon
34
AMCON Distributing
DIT
$58.6M
$1.47M 1.24%
12,000
– –
2020 Q4
13 quarters
BABA icon
35
Alibaba
BABA
$276B
$1.45M 1.22%
+20,000
New +$1.47M
2024 Q1
0 quarters
NWL icon
36
Newell Brands
NWL
$2.46B
$1.41M 1.18%
175,000
– –
2023 Q4
1 quarter
PFE icon
37
Pfizer
PFE
$168B
$1.39M 1.17%
50,000
– –
2023 Q4
1 quarter
B icon
38
Barrick Mining
B
$66.7B
$1.33M 1.12%
80,000
+30,000
+60% +$469K
2023 Q2
3 quarters
XOMA icon
39
DELISTED
Xoma
XOMA
$1.32M 1.11%
55,000
– –
2023 Q4
1 quarter
CRIS icon
40
Curis
CRIS
$1.23M
$1.3M 1.1%
6,000
+4,750
+380% +$1.02M
2022 Q4
5 quarters
RVNC icon
41
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.23M 1.03%
250,000
+175,000
+233% +$1.04M
2023 Q4
1 quarter
SABR icon
42
Sabre
SABR
$722M
$1.21M 1.02%
500,000
+200,000
+67% +$671K
2023 Q1
4 quarters
AVIR icon
43
Atea Pharmaceuticals
AVIR
$363M
$1.09M 0.92%
270,000
– –
2021 Q2
11 quarters
COYA icon
44
Coya Therapeutics
COYA
$102M
$992K 0.83%
100,000
– –
2023 Q2
3 quarters
NKTR icon
45
Nektar Therapeutics
NKTR
$1.29B
$878K 0.74%
62,656
– –
2020 Q4
13 quarters
PK icon
46
Park Hotels & Resorts
PK
$3.17B
$875K 0.73%
50,000
-10,000
-17% -$162K
2023 Q1
4 quarters
HRTX icon
47
Heron Therapeutics
HRTX
$71.5M
$831K 0.7%
300,000
-25,000
-8% -$62.8K
2020 Q4
13 quarters
CTSO icon
48
Cytosorbents Corp
CTSO
$9.64M
$784K 0.66%
41,250
+20,500
+99% +$399K
2021 Q1
12 quarters
ACAD icon
49
Acadia Pharmaceuticals
ACAD
$3.4B
$740K 0.62%
40,000
+10,000
+33% +$248K
2023 Q4
1 quarter
BATL icon
50
Battalion Oil
BATL
$59M
$736K 0.62%
130,000
+21,700
+20% +$151K
2020 Q4
13 quarters
1
2
3 4

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q1 2024 Portfolio in Review

As of Q1 2024, CM Management held 80 positions worth $119M, down 4.3% from $124M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management withdrew a net $5.42M in Q1 2024, closing 11 positions and reducing 7 holdings. Its most notable exit was Immunogen Inc, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Industrials and Technology.

Against the trend, CM Management opened a new position in Incyte worth $1.71M.

  • CM Management's largest Q1 2024 buy was Incyte: 30,000 shares worth $1.71M.
  • CM Management added most to Walgreens Boots Alliance in Q1 2024, an estimated $1.67M increase.
  • CM Management's biggest Q1 2024 reduction was BGC Group, cutting an estimated $1.85M.
  • CM Management fully exited Immunogen Inc in Q1 2024, selling an estimated $14.8M.
  • CM Management's ten largest holdings make up 37% of its $119M portfolio in Q1 2024.
  • CM Management opened 8 new positions and closed 11 in Q1 2024.
  • CM Management's portfolio value fell 4.3% quarter-over-quarter to $119M.

Based on CM Management's 13F filing for Q1 2024, filed 14 May 2024.